Immediate Impact
2 from Science/Nature 67 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Jinjin Liang being referenced
Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jinjin Liang | 295 | 248 | 1 | 119 | 33 | 560 | |
| Christine J. Picard | 167 | 245 | 31 | 39 | 629 | ||
| Takashi Matsuyama | 45 | 147 | 11 | 58 | 50 | 459 | |
| Xiaoli Liu | 162 | 23 | 97 | 37 | 606 | ||
| Xiaocong Li | 391 | 70 | 45 | 22 | 615 | ||
| Jina Ryu | 217 | 20 | 13 | 26 | 463 | ||
| Meimei Wang | 260 | 85 | 51 | 29 | 636 | ||
| Eric L. Carter | 249 | 7 | 39 | 23 | 603 | ||
| Vadim Kumeiko | 211 | 12 | 70 | 53 | 618 | ||
| Víctor H. Casco | 139 | 48 | 27 | 46 | 595 | ||
| Natália Cestari Moreno | 254 | 33 | 36 | 18 | 622 |
All Works
Loading papers...